Combination‐therapy with concurrent deferoxamine and deferiprone is effective in treating resistant cardiac iron‐loading in aceruloplasminaemia

No abstract is available for this paper.

• Publication year

  2015

• Venue

  British Journal of Haematology

• Publication date

  2015-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bjh.13401PMID 25855051
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aceruloplasminemia

  2015cited by this paper
• Deferiprone for the treatment of Friedreich's ataxia

  2013cited by this paper
• Criteria for early identification of aceruloplasminemia.

  2011cited by this paper
• Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up

  2011cited by this paper
• Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation

  2010influential reference
• Aceruloplasminemia: A novel mutation in a family with marked phenotypic variability

  2008cited by this paper
• A Randomized, Placebo-Controlled, Double-Blind Trial of the Effect of Combined Therapy With Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia Major Using Cardiovascular Magnetic Resonance

  2007cited by this paper
• Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis.

  2006cited by this paper
• A Randomized, Placebo Controlled, Double Blind Trial of the Effect of Combined Therapy with Deferoxamine and Deferiprone on Myocardial Iron in Thalassaemia Major Using Cardiovascular Magnetic Resonance.

  2005cited by this paper
• Use of desferrioxamine in the treatment of aceruloplasminemia

  1997cited by this paper

• New Approaches and Strategies for the Repurposing of Iron Chelating/Antioxidant Drugs for Diseases of Free Radical Pathology in Medicine

  2025cites this paper
• A Novel Mutation Related to Aceruloplasminemia with Mild Clinical Findings: A Case Report

  2024cites this paper
• The Vital Role Played by Deferiprone in the Transition of Thalassaemia from a Fatal to a Chronic Disease and Challenges in Its Repurposing for Use in Non-Iron-Loaded Diseases

  2023cites this paper
• New view of aceruloplasminemia: systemic review and meta-analysis tracking dots from onset to disease development and iron-related features

  2023cites this paper
• Iron Load Toxicity in Medicine: From Molecular and Cellular Aspects to Clinical Implications

  2023cites this paper
• A New Pathogenic Missense Variant in a Consanguineous North-African Family Responsible for a Highly Variable Aceruloplasminemia Phenotype: A Case-Report

  2022cites this paper
• HIF-1α Regulates Bone Homeostasis and Angiogenesis, Participating in the Occurrence of Bone Metabolic Diseases

  2022cites this paper
• Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders

  2021cites this paper
• Deferasirox Might Be Effective for Microcytic Anemia and Neurological Symptoms Associated with Aceruloplasminemia: A Case Report and Review of the Literature

  2020cites this paper
• Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reports

  2020cites this paper
• Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis

  2019cites this paper
• Aceruloplasminemia: Waiting for an Efficient Therapy

  2018cites this paper
• Deferoxamine loaded titania nanotubes substrates regulate osteogenic and angiogenic differentiation of MSCs via activation of HIF-1α signaling.

  2018cites this paper
• New targeted therapies and diagnostic methods for iron overload diseases.

  2018cites this paper
• New insights in the neurological phenotype of aceruloplasminemia in Caucasian patients.

  2017cites this paper
• Chelating Therapy in Metal Storage Diseases

  2016cites this paper
• Diagnosis and Evaluation of Metal Poisonings and Chelation Therapy

  2016cites this paper
• Chelation Therapy in the Treatment of Metal Intoxication

  2016cites this paper
• Iron chelation in the treatment of neurodegenerative diseases.

  2016cites this paper